Observational studyPloS one2016

Early 18F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.

Erik J van Helden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.